SCHEMBL1818007

SCHEMBL1818007

COc1cc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc(C)cc2)CCO3)ccc1C#N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 3/20 0.56
▸ KMT2A Q03164 5/20 0.48
▸ NPC1 O15118 1/20 0.47
▸ MEN1 O00255 4/20 0.44
▸ MAPT P10636 4/20 0.44
▸ TP53 P04637 2/20 0.44
▸ CYP3A4 P08684 3/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ PKM P14618 4/20 0.41
▸ USP2 O75604 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CPT2 P23786 1/20 0.39
▸ CPT1A P50416 1/20 0.39
▸ CPT1B Q92523 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ AR P10275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1818577 0.92 NPC1 (0.58) CYP2C9KMT2ANPC1MEN1MAPT
SCHEMBL1816318 0.91 NPC1 (0.47) CYP2C9KMT2ANPC1MEN1MAPT
SCHEMBL1819920 0.91 NPC1 (0.47) CYP2C9KMT2ANPC1MEN1MAPT
SCHEMBL1818967 0.91 CYP2C9 (0.48) CYP2C9KMT2ANPC1MEN1MAPT
SCHEMBL1818733 0.90 CYP2C9 (0.47) CYP2C9KMT2ANPC1MEN1MAPT
SCHEMBL1819412 0.90 NPC1 (0.45) CYP2C9KMT2ANPC1MEN1MAPT
SCHEMBL1820258 0.89 NPC1 (0.45) CYP2C9KMT2ANPC1MEN1MAPT
SCHEMBL1816628 0.88 POLB (0.45) CYP2C9KMT2ANPC1MEN1MAPT
SCHEMBL1817694 0.88 POLB (0.46) CYP2C9KMT2ANPC1MEN1MAPT
SCHEMBL1819918 0.87 NPC1 (0.48) CYP2C9KMT2ANPC1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback